Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Forte Biosciences
FBRX
$130M
| $213K | ﹤0.01% |
8,192
-348
| -4% | -$9.05K |
|
3277
Gain Therapeutics
GANX
$61.8M
| $213K | ﹤0.01% |
47,600
+8,900
| +23% | +$39.8K |
|
3278
Century Therapeutics
IPSC
$44.8M
| $213K | ﹤0.01% |
67,300
-85,801
| -56% | -$272K |
|
3279
Midland States Bancorp
MSBI
$392M
| $213K | ﹤0.01% |
10,700
-4,200
| -28% | -$83.6K |
|
3280
Trevi Therapeutics
TRVI
$1.19B
| $213K | ﹤0.01% |
89,300
-148,100
| -62% | -$353K |
|
|
CNTA
3281
Centessa Pharmaceuticals
CNTA
$3.04B
| $212K | ﹤0.01% |
34,300
+18,600
| +118% | +$115K |
|
3282
Entegris
ENTG
$12.6B
| $212K | ﹤0.01% |
1,910
-2,600
| -58% | -$289K |
|
3283
First Trust Dorsey Wright Focus 5 ETF
FV
$3.75B
| $211K | ﹤0.01% |
4,500
-14,000
| -76% | -$656K |
|
3284
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.5B
| $211K | ﹤0.01% |
+4,600
| New | +$211K |
|
3285
Schwab 1000 Index ETF
SCHK
$4.6B
| $210K | ﹤0.01% |
+9,800
| New | +$210K |
|
3286
First Internet Bancorp
INBK
$209M
| $209K | ﹤0.01% |
+14,100
| New | +$209K |
|
|
JT
3287
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $209K | ﹤0.01% |
189,669
-24,400
| -11% | -$26.9K |
|
3288
Cricut
CRCT
$1.38B
| $209K | ﹤0.01% |
17,100
-18,100
| -51% | -$221K |
|
3289
Skillful Craftsman
EDTK
$17.5M
| $209K | ﹤0.01% |
155,100
-4,100
| -3% | -$5.53K |
|
|
WRN
3290
Western Copper and Gold
WRN
$323M
| $208K | ﹤0.01% |
135,700
+94,177
| +227% | +$144K |
|
3291
Direct Digital Holdings
DRCT
$9.32M
| $207K | ﹤0.01% |
72,700
-37,615
| -34% | -$107K |
|
3292
Reviva Pharmaceuticals
RVPH
$30.1M
| $207K | ﹤0.01% |
35,300
+16,176
| +85% | +$94.9K |
|
|
VINC
3293
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $207K | ﹤0.01% |
7,955
-1,795
| -18% | -$46.7K |
|
3294
Achieve Life Sciences
ACHV
$161M
| $206K | ﹤0.01% |
39,600
-2,000
| -5% | -$10.4K |
|
3295
Humacyte
HUMA
$238M
| $205K | ﹤0.01% |
71,600
+23,900
| +50% | +$68.4K |
|
|
SDC
3296
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $205K | ﹤0.01% |
386,412
+93,100
| +32% | +$49.4K |
|
3297
Bank7 Corp
BSVN
$464M
| $204K | ﹤0.01% |
8,300
-752
| -8% | -$18.5K |
|
3298
FlexShopper
FPAY
$16.9M
| $204K | ﹤0.01% |
159,480
-19,800
| -11% | -$25.3K |
|
3299
Five Point Holdings
FPH
$418M
| $204K | ﹤0.01% |
70,700
+44,395
| +169% | +$128K |
|
3300
Dogness International Corp
DOGZ
$179M
| $203K | ﹤0.01% |
13,930
-3,005
| -18% | -$43.8K |
|